Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Assets (2016 - 2025)

Amphastar Pharmaceuticals has reported Current Assets over the past 13 years, most recently at $636.0 million for Q4 2025.

  • Quarterly results put Current Assets at $636.0 million for Q4 2025, up 19.09% from a year ago — trailing twelve months through Dec 2025 was $636.0 million (up 19.09% YoY), and the annual figure for FY2025 was $636.0 million, up 19.09%.
  • Current Assets for Q4 2025 was $636.0 million at Amphastar Pharmaceuticals, down from $639.5 million in the prior quarter.
  • Over the last five years, Current Assets for AMPH hit a ceiling of $639.5 million in Q3 2025 and a floor of $300.2 million in Q1 2021.
  • Median Current Assets over the past 5 years was $445.2 million (2023), compared with a mean of $456.2 million.
  • Biggest five-year swings in Current Assets: soared 41.33% in 2023 and later grew 0.54% in 2024.
  • Amphastar Pharmaceuticals' Current Assets stood at $318.1 million in 2021, then increased by 18.92% to $378.3 million in 2022, then grew by 29.41% to $489.6 million in 2023, then increased by 9.08% to $534.1 million in 2024, then grew by 19.09% to $636.0 million in 2025.
  • The last three reported values for Current Assets were $636.0 million (Q4 2025), $639.5 million (Q3 2025), and $580.8 million (Q2 2025) per Business Quant data.